Akonni Biosystems Wins $3M NIH Grant to Develop Portable Tuberculosis Diagnostic System
September 21, 2010
Akonni Biosystems Wins $3M NIH Grant to Develop Portable Tuberculosis Diagnostic System
Frederick, Md.-based Akonni plans to use the funding to support the development of its prototype MDR-TB PCR TruArray by expanding test coverage, completing the manufacturing scale-up for future kits, and performing pre-clinical verification experiments.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - CapitalBio Deafness Test Being Evaluated for Neonatal Screening in Three Major Chinese Cities
November 13, 2012 / BioArray News - Oslo University Hospital Licenses Colorectal Cancer Markers to OGT for Test Development
February 28, 2012 / BioArray News - Signal Genetics Taps NeoGenomics to Market Array-Based Myeloma Test to US Hospitals
May 31, 2011 / BioArray News - Akonni Biosystems Partners with Seegene to Develop POC Respiratory Disease Tests
May 10, 2011 / BioArray News